# GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety

> **NCT00645918** · NA · COMPLETED · sponsor: **Accumetrics, Inc.** · enrollment: 2800 (actual)

## Conditions studied

- Coronary Arteriosclerosis
- Acute Coronary Syndrome

## Interventions

- **DRUG:** clopidogrel
- **DRUG:** placebo
- **DRUG:** clopidogrel

## Key facts

- **NCT ID:** NCT00645918
- **Lead sponsor:** Accumetrics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 2800 (ACTUAL)
- **Last updated:** 2011-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00645918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00645918, "GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00645918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*